Portrait of PTEN: Messages from mutant mice

90Citations
Citations of this article
110Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

PTEN is a tumor suppressor gene mutated in many human sporadic cancers and in hereditary cancer syndromes such as Cowden disease. The major substrate of PTEN is phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P3), a second messenger molecule produced following PI3K activation induced by a variety of stimuli. PI(3,4,5)P3 activates the serine-threonine kinase Akt, which is involved in antiapoptosis, proliferation and oncogenesis. In mice, heterozygosity for a null mutation of Pten (Pten-/- mice) frequently leads to the development of a variety of cancers and autoimmune disease. Homozygosity for the null mutation (Pten-/- mice) results in early embryonic lethality, precluding the functional analysis of Pten in adult tissues and organs. To investigate the physiological functions of Pten in viable mice, we and other groups have used the Cre-loxP system to generate various tissue-specific Pten mutations. The present review will summarize results obtained from the study of conditional mutant mice lacking Pten in specific tissues, and discuss the possible biological and molecular explanations for why Pten deficiency leads to tumorigenesis. © 2007 Japanese Cancer Association.

Cite

CITATION STYLE

APA

Suzuki, A., Nakano, T., Mak, T. W., & Sasaki, T. (2008, February). Portrait of PTEN: Messages from mutant mice. Cancer Science. https://doi.org/10.1111/j.1349-7006.2007.00670.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free